<DOC>
	<DOCNO>NCT01363583</DOCNO>
	<brief_summary>This study prospective consecutive double-blinded randomize study effect PGI2 , prostacyclin ( epoprostenol , Flolan® ) versus placebo ( saline ) patient severe traumatic brain injury . All patient severe traumatic brain injury eligible inclusion . Inclusion criterion : verify traumatic brain injury , Glasgow Coma Score ( GCS ) intubation sedation ≤ 8 , age 15-70 year , first-recorded cerebral perfusion pressure ( CPP ) &gt; 10 mm Hg , arrival within 24 hour trauma . Tne primary aim evaluate whether treatment epoprostenol would reduce lactate/pyruvate ratio , measure cerebral microdialysis 24 hour treatment . A secondary aim evaluate effect epoprostenol systemic inflammatory marker , measure different cytokine .</brief_summary>
	<brief_title>Study Effect Prostacyclin Compared Placebo Traumatic Brain Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Epoprostenol</mesh_term>
	<mesh_term>Tezosentan</mesh_term>
	<criteria>traumatic brain injury , Glasgow coma scale ≤ 8 pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2001</verification_date>
	<keyword>traumatic brain injury</keyword>
</DOC>